Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabetes
Author(s) -
Cees J. Tack,
V. Christov,
Bastiaan E. de Galan,
Karl-Michael Derwahl,
Gerhard Klausmann,
Terezie Pelikánová,
Jindra Perušičová,
Anders Boss,
Nikhil Amin,
David Kramer,
Richard Petrucci,
Wen Yu
Publication year - 2008
Publication title -
journal of diabetes science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.039
H-Index - 75
eISSN - 1932-3107
pISSN - 1932-2968
DOI - 10.1177/193229680800200108
Subject(s) - postprandial , glycemic , medicine , insulin , placebo , diabetes mellitus , hemoglobin , endocrinology , insulin glargine , type 2 diabetes , type 1 diabetes , type 2 diabetes mellitus , hypoglycemia , basal (medicine) , alternative medicine , pathology
Individuals with type 2 diabetes mellitus have impairments in early insulin release, resulting in increased postprandial glucose excursions and suboptimal glycemic control. Studies with Technosphere Insulin (TI) indicate that it has rapid systemic absorption and a short duration of glucose-lowering activity, making it well suited for controlling postprandial glucose levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom